A Review in the Journal of Ethnic Foods finds that kimchi interventions may be safe and effective treatment option for general health, obesity, and irritable bowel syndrome. More research is required to prove these benefits.
] which was excluded from this review because it was not randomized controlled trial, involved 12 young female adults, 6 participants in each group. The trial interventions were low consumption of kimchi and high consumption of kimchi for 7 days, and reported the decrease in potentially harmful microorganism percentage in the high-consumption group. There were 34 species of intestinal microorganisms whose percentage changes between the two groups were significantly different .
In terms of anticancer and cancer prevention effects reported by previous studies, kimchi was found to have inhibitory effects of cancer cell growth for gastric cancer , lung cancer , colon cancer , breast cancer , liver cancer and uterine cancer []. Even though there are numerous cell and animal studies exploring anti-inflammation and anticancer effects of kimchi, clinical trial data on such effects are currently not available yet.
In this review, the included RCTs reported on lipid-lowering effects, colon health improvement, and anti-obesity effects of kimchi, although there were differences depending on the amount of kimchi consumed and the fermentation stage. Despite the differences in the types and amount of kimchi consumed, all kimchi consumption in general was found to have benefits in improving health.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Study highlights the potential long-term neurological effects post-COVID-19Study highlights the potential long-term neurological effects post-COVID-19 biorxivpreprint neurological postcovid COVID19 covid SARSCoV2 neurologicaleffects symptoms news research spikeproteins sprotein
Read more »
Identifying the potential causal role of insomnia symptoms on 11,409 health-related outcomes: a phenome-wide Mendelian randomisation analysis in UK Biobank - BMC MedicineBackground Insomnia symptoms are widespread in the population and might have effects on many chronic conditions and their risk factors but previous research has focused on select hypothesised associations/effects rather than taking a systematic hypothesis-free approach across many health outcomes. Methods We performed a Mendelian randomisation (MR) phenome-wide association study (PheWAS) in 336,975 unrelated white-British UK Biobank participants. Self-reported insomnia symptoms were instrumented by a genetic risk score (GRS) created from 129 single-nucleotide polymorphisms (SNPs). A total of 11,409 outcomes from UK Biobank were extracted and processed by an automated pipeline (PHESANT) for the MR-PheWAS. Potential causal effects (those passing a Bonferroni-corrected significance threshold) were followed up with two-sample MR in MR-Base, where possible. Results Four hundred thirty-seven potential causal effects of insomnia symptoms were observed for a diverse range of outcomes, including anxiety, depression, pain, body composition, respiratory, musculoskeletal and cardiovascular traits. We were able to undertake two-sample MR for 71 of these 437 and found evidence of causal effects (with directionally concordant effect estimates across main and sensitivity analyses) for 30 of these. These included novel findings (by which we mean not extensively explored in conventional observational studies and not previously explored using MR based on a systematic search) of an adverse effect on risk of spondylosis (OR [95%CI] = 1.55 [1.33, 1.81]) and bronchitis (OR [95%CI] = 1.12 [1.03, 1.22]), among others. Conclusions Insomnia symptoms potentially cause a wide range of adverse health-related outcomes and behaviours. This has implications for developing interventions to prevent and treat a number of diseases in order to reduce multimorbidity and associated polypharmacy.
Read more »
Inflammation May Be the Culprit Behind Our Deadliest Diseases'Low-level, invisible inflammation, simmering quietly in the blood of ostensibly healthy people, may be a common thread running through nearly all diseases,' writes Dr. Shilpa Ravella
Read more »
Pentagon leak shows S Korea torn on sending Ukraine weaponsThe document, seen by the BBC, reveals a conversation between high-level South Korean officials.
Read more »
New technique opens the door to safer gene editing by reducing the mutation problem in gene therapyCRISPR-Cas9 is widely used to edit the genome by studying genes of interest and modifying disease-associated genes. However, this process is associated with side effects including unwanted mutations and toxicity. Therefore, a new technology that reduces these side effects is needed to improve its usefulness in industry and medicine.
Read more »
Topical cannabidiol is well tolerated in individuals with a history of elite physical performance and chronic lower extremity pain - Journal of Cannabis ResearchIntroduction Cannabidiol (CBD) is a potential therapeutic for pain management. Yet, there exists a dearth of studies of its tolerability and efficacy, especially in special populations. Former elite athletes are a special population both susceptible to chronic pain and also highly trained and attuned to assess medication tolerability concerns. The purpose of the present open-label pilot study was to assess the tolerability of CBD in this population. Materials and methods Retrospective analysis was conducted in deidentified data from 20 individuals who were all previously professional athletes in US/American football, track and field, or basketball, with careers ranging from 4 to 10 years. Participants received topical CBD (10 mg twice daily by controlled dispenser) for chronic pain resulting from acute lower extremity injuries. Assessments of tolerability and secondary analyses of pain, pain-related disability, and activities of daily living were collected by self-report over the 6-week study period. Data were analyzed by descriptive statistics, pairwise t-test, and linear regression. Results Seventy percent of participants completed the study. Of the individuals who completed the study, 50% reported minor adverse effects, none of which required medical attention, and 50% did not report any adverse effects. The mostly commonly reported effects were skin dryness (43% of study completers) and skin rash (21% of study completers), which rapidly resolved. There was a significant improvement in self-reported pain levels (intake mean 3.5 ± 0.29; exit mean 1.7 ± 0.23; P | 0.001) and pain-related disability, including family and home responsibilities, life support activities, occupational activities, recreational activities, self-care, sexual function, and social activities (all P | 0.001). Discussion To the best of our knowledge, this is the first study to assess CBD treatment in elite athletes, who are disproportionally susceptible to disabling injuries. Topical administra
Read more »